Medical Value Travel in Vancouver Canada
Medical Value Travel in Vancouver section, includes general infrmation about Medical Value Travel Procedure, Medical Value Travel Vancouver Local News, Medical Value Travel Vancouver Surgeon Locator and other Medical Value Travel related material.
Medical Value Travel Procedure
Currently medical value tourists or medical value travelers from developed industrialized countries are traveling in large numbers abroad where the quality of healthcare is equal to or even better than the standards in their own country and yet the cost is significantly lower. Another factor behind Medical Value Travel is the promptness of treatment. These healthcare destination countries also offer numerous options for escapes to vacation touring trips, sight-seeing, shopping, exploring journeys and lounging on sun drenched exotic beaches for Medical Value Travelers.
A number of reasons have lead to the recent increase in the popularity of Medical Tourism or Medical Value Travel. Some of the reasons include overly exorbitant costs of basic health care and medical insurance cover, high cost of modern medical facilities in advanced countries, ease and affordability of international travel, favorable currency exchange rates in the global economy, rapidly improving technology and high standards of medical care in the developing countries, best medical health care education at the medical schools, proven safety of healthcare in select foreign nations, international accreditation of foreign hospitals and access to U.S., U.K. and Australian board certified surgeons operating in select foreign countries. All of the former contributed their share to this rapid development of Medical Tourism or Medical Value Travel.
In general, most Medical Value Tourists are either uninsured, underinsured or those seeking elective surgeries. Others resort to Medical Value Travel due to the long wait-lists or unavailability of certain procedures in their country.
Cosmetic Surgery procedures which are also known as 'elective' surgical procedures, whether carried out at home or abroad, raise concerns and anxieties for the patient. It is normal to have some doubts about the surgeon or the clinic where the procedure is going to be carried out. Legitimate concerns can also include safety, the qualifications of the surgeon performing the procedure, the after-care service given, the standard of the hospital being chosen, the duration of the flight time in consideration to the procedure being carried out and also the country where you are traveling to - in terms of whether it is somewhere where you will feel comfortable. The language barrier can also be a concern. These are all legitimate concerns which, bring up questions needing to be answered. The more information you can get in advance, the more confident you will be when you travel for surgery.
With an ever increasing demand for these types of procedures, these days a patient can look towards specific companies, which deal solely in putting together packages specifically aimed for cosmetic surgery abroad. These packages not only involve the application of plastic surgery procedures, or patients traveling from their home country to receive the work done, but can also include flights and after surgery accommodation.
For many Medical Value Travel procedures, you begin with convenient initial consultations online from your home. Arriving abroad at the treatment location, you receive private hospital support with nurses visiting your hotel room, then luxury spa treatments to soothe the nerves and comforting recovery kits to ease the pain.
Many consumers locate Medical Value Travel vacation destinations through the Internet. The websites of these destinations have contact forms so that the patient can communicate with the practice by email. Patients often scan a photo of the area that they are interested in improving and send it to the doctor for a recommendation.
More Vancouver info...
Vancouver Water Taxi
A quick trip across on a water taxi can be a fun and convenient way to get between various points on False Creek, including Granville Island, Science World, the Maritime Museum, downtown, and others. Service is offered by Granville Island Ferries [26] and Aquabus [27]. Current prices start at around $2.50 per journey - Sept 2006.
-
Vancouver Climate
With the exception of Victoria, Vancouver has the mildest climate of any major city in Canada; even palm trees can grow here. It can rain a lot in Vancouver, especially during the winters, but the temperature rarely goes below freezing. Snowfalls are an unusual sight and often lead to major traffic congestion. The weather in Vancouver is similar to the southern UK, and almost identical to Seattle's. In the early summer the days often start out cloudy, due to marine air, but becomes clear by noon. Contrary to Vancouver's wet reputation, during the summer it is actually the second driest major Canadian city (after Victoria). Summer temperatures are not extreme, the typical day time high between June and August is around 25°C (77°F).
-
Plastic Surgery News...
Context No antidiabetic regimen has demonstrated the ability to reduce progression of coronary atherosclerosis. Commonly used oral glucose-lowering agents include sulfonylureas, which are insulin secretagogues, and thiazolidinediones, which are insulin sensitizers.
Objective To compare the effects of an insulin sensitizer, pioglitazone, with an insulin secretagogue, glimepiride, on the progression of coronary atherosclerosis in patients with type 2 diabetes.
Design, Setting, and Participants Double-blind, randomized, multicenter trial at 97 academic and community hospitals in North and South America (enrollment August 2003-March 2006) in 543 patients with coronary disease and type 2 diabetes.
Interventions A total of 543 patients underwent coronary intravascular ultrasonography and were randomized to receive glimepiride, 1 to 4 mg, or pioglitazone, 15 to 45 mg, for 18 months with titration to maximum dosage, if tolerated. Atherosclerosis progression was measured by repeat intravascular ultrasonography examination in 360 patients at study completion.
Main Outcome Measure Change in percent atheroma volume (PAV) from baseline to study completion.
Results Least squares mean PAV increased 0.73% (95% CI, 0.33% to 1.12%) with glimepiride and decreased 0.16% (95% CI, –0.57% to 0.25%) with pioglitazone(P = .002). An alternative analysis imputing values for noncompleters based on baseline characteristics showed an increase in PAV of 0.64% (95% CI, 0.23% to 1.05%) for glimepiride and a decrease of 0.06% (–0.47% to 0.35%) for pioglitazone (between-group P = .02). Mean (SD) baseline HbA1c levels were 7.4% (1.0%) in both groups and declined during treatment an average 0.55% (95% CI, –0.68% to –0.42%) with pioglitazone and 0.36% (95% CI, –0.48% to –0.24%) with glimepiride (between-group P = .03). In the pioglitazone group, compared with glimepiride, high-density lipoprotein levels increased 5.7 mg/dL (95% CI, 4.4 to 7.0 mg/dL; 16.0%) vs 0.9 mg/dL (95% CI, –0.3 to 2.1 mg/dL; 4.1%), and median triglyceride levels decreased 16.3 mg/dL (95% CI, –27.7 to –11.0 mg/dL; 15.3%) vs an increase of 3.3 mg/dL (95% CI, –10.7 to 11.7 mg/dL; 0.6%) (P < .001 for both comparisons). Median fasting insulin levels decreased with pioglitazone and increased with glimepiride (P < .001). Hypoglycemia was more common in the glimepiride group and edema, fractures, and decreased hemoglobin levels occurred more frequently in the pioglitazone group.
Conclusion In patients with type 2 diabetes and coronary artery disease, treatment with pioglitazone resulted in a significantly lower rate of progression of coronary atherosclerosis compared with glimepiride.
Trial Registration clinicaltrials.gov Identifier: NCT00225277
Published online March 31, 2008 (doi:10.1001/jama.299.13.1561).
- FDA has not appropriately debarred a number of individuals and pharmaceutical companies convicted of crimes from participation in the agency approval process for medications, according to a report presented on Monday by House Energy and Commerce Committee Republicans, Bloomberg/New York Times reports (Bloomberg/New York Times, 2/12).